Carcinoma, Hepatocellular: all 3,249 studies
Page 30 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- TheraSphere for the Treatment of Unresectable Hepatocellular CarcinomaCompletedNCT01349075
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular CarcinomaTerminatedNCT01348503Phase 1
- Stiffness Measurement of Liver Tumors and Visceral ParenchymaStatus unknownNCT01343212
- Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic CirrhosisTerminatedNCT01342705Phase 3
- Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast AgentsStatus unknownNCT01341132
- Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency AblationCompletedNCT01340105Not applicable
- Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)TerminatedNCT01337492Early Phase 1
- Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and BiomarkersStatus unknownNCT01336452Not applicable
- Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT01335074Phase 1/2
- Study of Axitinib in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01334112Phase 2
- Drug-eluting Bead in Hepatocellular CarcinomaCompletedNCT01332669Phase 4
- Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01328223
- Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular CarcinomaWithdrawnNCT01327521Phase 3
- Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular CarcinomaTerminatedNCT01326390
- PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)CompletedNCT01320852Not applicable
- Combined Radiotherapy and Sorafenib in Patients With HepatomaStatus unknownNCT01319942
- Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)WithdrawnNCT01318200Phase 3
- An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423CompletedNCT01316679
- The Development of Diagnostic Biomarker Panels for Hepatitis and Liver CancerStatus unknownNCT01310062
- A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular CarcinomaCompletedNCT01308723Phase 1
- Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)Status unknownNCT01308645Phase 2
- Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular CarcinomaCompletedNCT01300143Phase 2
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic TherapyCompletedNCT01287585Phase 3
- Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular CancerWithdrawnNCT01281943Phase 2
- Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional TherapyStatus unknownNCT01281683
- Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular CarcinomaStatus unknownNCT01277653
- Axitinib as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01273662Phase 2
- Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II TrialStatus unknownNCT01272557Phase 2
- Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
- Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular CarcinomaStatus unknownNCT01266707Phase 1
- Caphosol in Oral Mucositis Due to Targeted TherapyCompletedNCT01265810Phase 3
- Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)Status unknownNCT01265576Phase 2
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedNCT01263002Phase 4
- Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular CarcinomaCompletedNCT01259414Phase 3
- Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCCStatus unknownNCT01259193Phase 2
- Hepatocellular Carcinoma (HCC)_Torisel_CompletedNCT01251458Phase 1/2
- Different Genetic Features Associated With Hepatic CarcinogenesisStatus unknownNCT01247506
- Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWithdrawnNCT01245582Phase 3
- East-West Hepatocellular Carcinoma Study GroupCompletedNCT01237132
- Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCCStatus unknownNCT01236989Not applicable
- Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining EmbolotherapyStatus unknownNCT01236690Phase 2
- Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)Status unknownNCT01230697
- Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCCCompletedNCT01229839Phase 3
- A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.TerminatedNCT01219543Phase 1
- Transcatheter Arterial Chemoembolization Therapy In Combination With SorafenibStatus unknownNCT01217034Phase 2
- MRI of the Liver With EovistTerminatedNCT01215838
- Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNCT01215565Phase 2
- Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCCStatus unknownNCT01214343Phase 3
- Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.CompletedNCT01204177Phase 2
- Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic CirrhosisStatus unknownNCT01201655
- Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01198704
- Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or TransplantWithdrawnNCT01194206Phase 2
- A Study of Apatinib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01192971Phase 2
- GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study StartWithdrawnNCT01191385
- Proteomic Analysis of Human Hepatocellular CarcinomaCompletedNCT01177631Not applicable
- Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01176604Not applicable
- Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular CarcinomaTerminatedNCT01171482Phase 2
- Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01170104Phase 2
- Carbon Ion Radiotherapy for Hepatocellular CarcinomaTerminatedNCT01167374Not applicable
- Stereotaxic Irradiation of Hepatocellular CarcinomaCompletedNCT01165346Phase 2
- Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01157013Not applicable
- Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without SteroidsCompletedNCT01137084Not applicable
- Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01135056Phase 3
- Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular CarcinomaCompletedNCT01131689Phase 1
- Siliphos in Advanced Hepatocellular CarcinomaCompletedNCT01129570Phase 1
- Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein ResponseTerminatedNCT01128803Phase 1/2
- Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver CancerCompletedNCT01126645Phase 2
- 188RE-SSS Lipiodol to Treat HepatoCellular CarcinomasCompletedNCT01126463Phase 1
- Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT01125020Not applicable
- Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)CompletedNCT01116804Phase 1
- Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)CompletedNCT01116635Phase 1/2
- Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib TreatmentTerminatedNCT01108705Phase 3
- Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) TherapyStatus unknownNCT01102335Phase 4
- A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCCTerminatedNCT01101906Phase 2
- Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese PatientsCompletedNCT01098760Phase 4
- Radiofrequency Versus Laser Ablation for Hepatocellular CarcinomaCompletedNCT01096914Not applicable
- Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)CompletedNCT01092091Phase 1/2
- Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular CarcinomaCompletedNCT01088581Phase 3
- Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver ElasticityCompletedNCT01082419Not applicable
- Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)CompletedNCT01078415Not applicable
- Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01078311
- A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular CarcinomaApproved for marketingNCT01076517
- The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular CarcinomaStatus unknownNCT01055743Phase 2
- Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
- Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular CarcinomasCompletedNCT01040559Phase 1
- Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular CancerCompletedNCT01034865
- Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisStatus unknownNCT01033578Not applicable
- AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
- Raltegravir in Patients With End Stage Liver Disease and in Transplant RecipientsCompletedNCT01022476Phase 1/2
- Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C InfectionCompletedNCT01018381Not applicable
- Regulatory Post Marketing Surveillance Study on Nexavar®CompletedNCT01012011
- Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
- Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01008917Phase 1
- Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular TechniqueCompletedNCT01008657Not applicable
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01008566Phase 1
- Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01008358Phase 2
- Safety Study of BAY73-4506 in Patients With Hepatocellular CarcinomaCompletedNCT01003015Phase 2
- Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer PatientsCompletedNCT00999882Phase 1
- Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver CancerStatus unknownNCT00999843Phase 1/2
- Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant PatientsCompletedNCT00997022Phase 1